Toxicologic effects of ribavirin in cats (Q33493051)

27 July 2017

Toxicologic effects of ribavirin in cats (English)

1 reference

27 July 2017

1 reference

Weiss RC

1

1 reference

PubMed ID

8230401

27 July 2017

Cox NR

series ordinal

2

1 reference

PubMed ID

8230401

27 July 2017

Boudreaux MK

series ordinal

3

1 reference

27 July 2017

1 September 1993

1 reference

Journal of Veterinary Pharmacology and Therapeutics

27 July 2017

1 reference

27 July 2017

16

1 reference

27 July 2017

3

1 reference

27 July 2017

301-316

1 reference

Delivery of liposome-encapsulated drugs to macrophages

27 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Effects of ribavirin on red blood cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Hematological and bone marrow effects of ribavirin in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Morphological alterations in blood and bone marrow of ribavirin-treated monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Effect of Ribavirin on Murine Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Properties of antiviral agents. 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Feline immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2885.1993.TB00177.X

Alopecia associated with ribavirin administration in rabbits.

21 January 2018

1 reference

12 December 2020

In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus

1 reference

12 December 2020

Ribavirin: a role in HIV infection?

1 reference

12 December 2020

Promising new antiviral drugs

1 reference

12 December 2020

Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis.

1 reference

12 December 2020

Disseminated intravascular coagulation in experimentally induced feline infectious peritonitis

1 reference

12 December 2020

Effect of orally administered ribavirin on experimental feline calicivirus infection in cats

1 reference

12 December 2020

A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group

1 reference

12 December 2020

1 reference

12 December 2020

10.1111/J.1365-2885.1993.TB00177.X

Identifiers

DOI

1 reference

27 July 2017

0 references

1 reference

PubMed ID

8230401